This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Mylan Laboratories Limited. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Nageshwara Rao Karusala: Innovator in Pharmaceutical Chemistry
Introduction
Nageshwara Rao Karusala is a notable inventor based in Hyderabad, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. His work has led to advancements in medication formulations that can improve patient outcomes.
Latest Patents
Nageshwara Rao Karusala holds a patent for a novel crystalline compound known as Carvedilol phosphate sesquihydrate. This invention relates to a unique crystalline form of 1-(Carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol phosphate sesquihydrate, also referred to as Carvedilol dihydrogenphosphate sesquihydrate. The patent outlines methods for preparing this sesquihydrate by adding phosphoric acid to a suspension of Carvedilol in water, water miscible solvents, or a mixture of both, followed by the isolation of the product.
Career Highlights
Nageshwara Rao Karusala is currently associated with Mylan Laboratories Limited, a leading global pharmaceutical company. His role involves research and development, focusing on innovative drug formulations that address various health issues. His expertise in pharmaceutical chemistry has been instrumental in the advancement of new therapeutic options.
Collaborations
Throughout his career, Nageshwara has collaborated with several professionals in the field. Notable coworkers include Seeta Ramanjaneyulu Gorantla and Mohan Bandari, who have contributed to various projects alongside him.
Conclusion
Nageshwara Rao Karusala is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patent for Carvedilol phosphate sesquihydrate exemplifies his commitment to improving healthcare through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
